PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
|Articles|May 2, 2020
- Pharmaceutical Technology-05-02-2020
- Volume 44
- Issue 5
Laser-Marked Smart Containers
Smart Containers from SCHOTT work to improve reject management and line clearance via a unique identifier to create traceability throughout the manufacturing process.
Smart Containers from SCHOTT work to improve reject management and line clearance via a unique identifier to create traceability throughout the manufacturing process. Each vial is laser-marked with a 1 x 1 mm data matrix code on the bottom, eliminating the need to turn the container or install multiple cameras. The code stays active throughout the entire fill/finish process including washing, autoclaving, and depyrogenation up to a temperature of 600 °C and resists abrasion and particle contamination.
The containers also reduce the risk of mix-up, optimize lyophilization processes, and support container-based targeted recalls. SCHOTT recommends linking the code to the container early on in the manufacturing process for the best results.
Articles in this issue
over 6 years ago
Modern Drug Manufacturing Key to COVID-19 Responseover 6 years ago
How Fast Is Too Fast?over 6 years ago
Starting a Career in the Bio/Pharmaceutical Industryover 6 years ago
Can We Teach an Old Drug New Tricks?over 6 years ago
Good Manufacturing Practices: Aseptic and Sterile Processingover 6 years ago
Small-Volume Conversion Kit for Bathless Dissolution Testersover 6 years ago
Inline High Shear Mixersover 6 years ago
Pre-Packed ColumnsRelated to this article
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.